September 2018—Agilent Technologies has entered into a definitive agreement to acquire ProZyme, a provider of glycan analysis reagents, kits, and standards. The acquisition will expand Agilent’s portfolio of biopharma consumables.
In a separate release, Agilent announced it has completed the acquisition of Ultra Scientific, a provider of chemical standards and certified reference materials.
Pages: 1 2